A função da MMP‐2 e MMP‐9 na metástase e no desenvolvimento de carcinoma hipofaríngeo
- 1 September 2021
- journal article
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 87 (5) , 521-528
Abstract
No abstract availableFunding Information
- Natural Science Foundation of Shandong Province (ZR2018HL011)
This publication has 26 references indexed in Scilit:
- Current management strategy of hypopharyngeal carcinomaAuris Nasus Larynx, 2013
- Current trends in initial management of hypopharyngeal cancer: The declining use of open surgeryHead & Neck, 2010
- Physiology and pathophysiology of matrix metalloproteasesAmino Acids, 2010
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Trafficking and differentiation of mesenchymal stem cellsJournal of Cellular Biochemistry, 2009
- National Cancer Database report on cancer of the head and neck: 10‐Year updateHead & Neck, 2009
- Imaging matrix metalloproteinases in cancerCancer and Metastasis Reviews, 2008
- Cancer of the pharynx and larynxThe American Journal of Medicine, 2001
- A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu miceEuropean Journal of Cancer, 2001
- Cervical node metastases in laryngeal and hypopharyngeal cancer: A prospective analysis of prevalence and distributionHead & Neck, 2000